Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
41.2M
-
Number of holders
-
14
-
Total shares
-
2.47M
-
Shares change
-
+548K
-
Total reported value, excl. options
-
$7.5M
-
Value change
-
+$1.66M
-
Number of buys
-
4
-
Number of sells
-
-5
-
Price
-
$3.04
Significant Holders of PolyPid Ltd. - Common Shares (PYPD) as of Q4 2024
15 filings reported holding PYPD - PolyPid Ltd. - Common Shares as of Q4 2024.
PolyPid Ltd. - Common Shares (PYPD) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.47M shares
of 41.2M outstanding shares and own 5.99% of the company stock.
Largest 10 shareholders include Rosalind Advisors, Inc. (1.02M shares), AIGH Capital Management LLC (828K shares), DAFNA Capital Management LLC (291K shares), J. Goldman & Co LP (128K shares), Stonepine Capital Management, LLC (104K shares), ADAR1 Capital Management, LLC (80.1K shares), Yelin Lapidot Holdings Management Ltd. (11.2K shares), Steward Partners Investment Advisory, LLC (7.35K shares), MORGAN STANLEY (878 shares), and BNP PARIBAS FINANCIAL MARKETS (834 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.